Sleep apnoea treatment developer Cryosa raised $21m in a Hoya-backed series B round while CommerzVentures led a $17m round for financial tool developer Doconomy .

Co-founded by Harvard faculty, Garuda has launched with $72m in series A financing to advance blood stem cell therapies.

Prosus, Visa, and Prudential Financial scored exits as Remitly went public, with Prudential divesting $32.5m of shares through the offering.

SoftBank Vision Fund 2 led a series C round for the life science robotics developer at a reported valuation of $1.8bn.

M12 has reinvested in document management software provider PandaDoc at a $1bn valuation having first backed it in 2017.

HSBC Ventures has pledged to back growth-stage climate technology developeres, providing them with the bank’s resources and network as well as capital.

Intuit’s newly formed venture capital arm will invest in early and growth-stage businesses solving a variety of problems in the financial and business services sectors.

Boston Scientific will pay $269m for the 84% of the thrombectomy technology developer that it does not currently own.

Mass General Brigham Ventures was among the participants in a series A round announced at the launch of the blood stem cell-focused startup.

Vijay Reddy, formerly an AI and deeptech-focused partner at Intel Capital, has departed from its parent company and joined venture firm Clear Ventures in a similar position.